Effects of Physiotherapy Via Telerehabilitation in Patients With COVID-19

NCT06251011 | Completed

• 1 other identifier: EC014/2565
• Study Type: interventional
• Target: 32
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to evaluate the effects of Physiotherapy Via Video Calls on Cardiopulmonary Functions, Physical Function, Cognitive Function, Activity Daily Livings, and Quality of Life in Patients With COVID-19.

Conditions

COVID-19; Long COVID-19; Cardiopulmonary Function; Physical Function

Outcome Measures

Primary Outcomes (7)

• Cardiopulmonary function

  using Cardiopulmonary exercise testing (CPET)

  at day 28 and 90 after positive in COVID-19 testing

• Patient's quality of life

  using the The World Health Organization Quality of Life (WHOQOL-BREF-THAI) 26 items; the final score ranges from 24-120; higher score means participants satisfied with the quality of life.

  at day 3 and 21 after positive in COVID-19 testing

• Functional capacity

  using Duke Activity status index The final score ranges between zero and 58.2 points; The higher the score, the better the functional capacity.

  at day 3 and 21 after positive in COVID-19 testing

• Anxiety and depression

  using Hospital Anxiety and Depression Scale (HADS) The total score is the sum of the 14 items, and for each subscale the score is the sum of the respective seven items (ranging from 0-21). A total subscale score of \>8 points out of a possible 21 denotes considerable symptoms of anxiety or depression.

  at day 3 and 21 after positive in COVID-19 testing

• Insomnia

  using Insomnia Severity Index (ISI) The final score ranges between zero and 28 points. The total score is interpreted as follows: absence of insomnia (0-7); sub-threshold insomnia (8-14); moderate insomnia (15-21); and severe insomnia (22-28).

  at day 3 and 21 after positive in COVID-19 testing

• Cognitive function

  using Thai Mental State Examination The final score ranges between zero and 30 points. A score of 25 or higher is classed as normal. If the score is below 24, the result is usually considered to be abnormal, indicating possible cognitive impairment.

  at day 3 and 21 after positive in COVID-19 testing

• Muscle strength

  using 1-minute sit to stand

  at day 3 and 21 after positive in COVID-19 testing

Study Arms (2)

Control group

NO INTERVENTION

Receive an advice and a leaflet for cardiopulmonary rehabilitation.

Physiotherapy group

EXPERIMENTAL

Receive the physical therapy training via video call (Pulmonary training, Calisthenic exercise, Upper and lower limbs strengthening exercise, Core stabilizer exercise, Aerobic exercise) at day 3, 6, 9, 12, 16, and 21 after positive in COVID-19 testing and also receive advise and a leaflet for cardiopulmonary rehabilitation.

Behavioral: Exercise training

Interventions

Exercise training BEHAVIORAL

1. Physical therapy training via video call 2. An advise and a leaflet for cardiopulmonary rehabilitation

Physiotherapy group

Eligibility Criteria

• Age: 20 Years - 60 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64)

You may qualify if:

• Age between 20-60 years old
• Positive in COVID-19 testing
• Good communication and understanding
• Independent mobility

You may not qualify if:

• Cannot complete the study protocol

Sponsors & Collaborators

• Chulabhorn Hospital: lead

Study Sites (1)

Chulabhorn hospital

Lak Si, Bangkok, 10210, Thailand

Location

MeSH Terms

Conditions

COVID-19; Post-Acute COVID-19 Syndrome

Interventions

Exercise

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Post-Infectious Disorders; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Motor Activity; Movement; Musculoskeletal Physiological Phenomena; Musculoskeletal and Neural Physiological Phenomena

Study Officials

• Pooriput Waongenngarm, PhD

  Chulabhorn Royal Academy

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor

Study Record Dates

• First Submitted: February 7, 2024
• First Posted: February 9, 2024
• Study Start: February 9, 2024
• Primary Completion: June 1, 2024
• Study Completion: June 4, 2024
• Last Updated: June 5, 2024

Record last verified: 2024-06

Data Sharing

• IPD Sharing: Will not share

Locations

TH (1)